1. Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers
   Andrew L. Pecora et al, 2002, Journal of Clinical Oncology CrossRef
2. Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
   null Schirrmacher et al, 2019, Biomedicines CrossRef
3. Newcastle disease virus - effective alliance in the fight against cancer
   A. O. Sitkovskaya et al, 2019, Siberian journal of oncology CrossRef
4. Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
   Bharat Burman et al, 2020, Cancers CrossRef
5. In Vitro and In Vivo Metabolomic Profiling after Infection with Virulent Newcastle Disease Virus
   Panrao Liu et al, 2019, Viruses CrossRef
6. Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive traet
   Wei Liang, 2003, World Journal of Gastroenterology CrossRef
7. New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection
   Volker Schirrmacher, 2020, Biomedicines CrossRef
8. Enhanced Replication of Virulent Newcastle Disease Virus in Chicken Macrophages Is due to Polarized Activation of Cells by Inhibition of TLR7
   Pingze Zhang et al, 2018, Frontiers in Immunology CrossRef
9. TNF-Related Apoptosis-Inducing Ligand Mediates Tumoricidal Activity of Human Monocytes Stimulated by Newcastle Disease Virus
   Birgit Washburn et al, 2003, The Journal of Immunology CrossRef